CASP3 and neuroblastoma: A recent study has demonstrated that the treatment of human-derived neuroblastoma cells with chelerythrine triggered a regulated form of necrotic cell death induced by an increase of ROS levels, which elicited an overactivation of caspases, caspase-3 included18.